Search for European Projects

10 European Projects Found

Searched on 125080 European Projects

 FINISHED 
MarPipe is a consortium of 11 partners (IBP-CNR, SZN, UiT, UNIABDN, GEOMAR, KULeuven, UCC, eCOAST, MEDINA, MicroDish, Italbiotec) based in 8 countries (I, N, UK, D, B, IRL, E, NL), including 3 from the non-academic sector. We will train 11 ESRs in marine drug-discovery, providing these researchers with unique skills toward becoming world leaders in this research field and to advance their careers ...
Read Project

 11

 FINISHED 

European Gram Negative Antibacterial Engine (ENABLE)

Start date: Feb 1, 2014, End date: Jan 31, 2020,

The intensive use and misuse of antibiotics has resulted in some level of antibiotic resistance in essentially all human bacterial pathogens. There is a growing concern that the loss of therapeutic options will present us with a post-antibiotic era where present and future medical advances are negated. Resistant bacteria dramatically reduce the possibilities of treating infections effectively, a ...
Read Project

 42

 FINISHED 

Ocean Medicines

Start date: Dec 1, 2015, End date: Nov 30, 2019,

Marine organisms have the capacity to produce a variety of biologically potent natural products. Such novel molecules have new mechanisms of action and therefore could be used to treat human diseases and enhance the quality of life, especially in the ageing segment of the population. However, although there is growing interest in marine natural products (MNP) as potential therapeutic agents for hu ...
Read Project

 9

 FINISHED 
...p with four internationally-leading counterparts at the EU level: the University of Helsinki, Finland, the University of Bergen, Norway, GEOMAR, Helmholtz Centre for Ocean Research Kiel, Germany, and Fundación MEDINA, Spain. BLUEandGREEN scientific strategy includes: to review the latest research and innovation advances in the sector, identify and address institutional network gaps and deficienci ...
Read Project

 5

 FINISHED 
"MICROSMETICS aims to discover and carry to the stage of development innovative products in the area of cosmeceuticals originating from global biodiversity using emerging and state of the art technologies in the field of biotechnology, natural products chemistry and applied microbiology. These objectives will be implemented through an extended and balanced scheme of researcher’s exchanges and recr ...
Read Project

 8

 FINISHED 
The PharmaSea project focuses on obstacles in marine biodiscovery research, development and commercialization and brings together a broad interdisciplinary team of academic and industry researchers and specialists to address and overcome these. The partners are ideally placed to demonstrate how to widen the bottlenecks and increase the flow of ideas and products derived from the marine microbiome ...
Read Project

 25

 FINISHED 
TOPCAPI will exploit the natural fabrication power of actinomycetes as microbial cell factories to produce three high value compounds: GE2270, a starter compound for the semi-synthesis of NAI-Acne, a new topical anti-acne drug in Phase II clinical trials; 6-desmethyl-tetracycline (6DM-TC) and 6-desmethyl 6-deshydro tetracycline (6DM6DH-TC), intermediates for semi-synthetic conversion to medically ...
Read Project

 8

 FINISHED 
Parasites exact a devastating toll on health and economic productivity, infecting man and also domestic livestock. Drugs used to combat parasitic diseases are deficient in many ways and new, better drugs are needed to establish sustainable means to combat diseases caused by protozoan parasites that include malaria, trypanosomiasis and leishmaniasis in man, and coccidiosis among others in animals. ...
Read Project

 12

 FINISHED 
Natural products have inspired chemists by their rich structural diversity and complexity while playing a pivotal role as sources for drug lead compounds during the last century. However, in order for natural products chemistry to continue to be competitive with purely synthetic based drug discovery methods, there is a need to continually improve the efficiency of the source selection, screening, ...
Read Project

 1

 FINISHED 
New antibiotics are urgently needed to combat persistent, emerging and re-emerging infectious diseases. Historically, microbial natural products have been a prolific source of antibacterials, and the screening of microbial extracts has yielded many classes of antibiotics. However, this approach was largely abandoned by big pharma because of the high rates of rediscovery of known antibiotics, and t ...
Read Project

 1